Thyroid cancers (TCs) are the most common tumors of the endocrine system and a constant
rise in the number of TC cases has been observed for the past few decades. TCs are one of …

Simple Summary Radioactive iodine treatment is the oldest targeted therapy for
differentiated thyroid cancer. It can be used for normal thyroid remnant ablation (in order to …

Astatine (211At) is an alpha-emitter with a better treatment efficacy against differentiated
thyroid cancer compared with iodine (131I), a conventional beta-emitter. However, its …

Context It is unclear whether radioactive iodine (RAI) therapy could improve cancer-specific
survival (CSS) in patients with Hürthle cell carcinoma (HCC) of the thyroid. Objective To …

It remains controversial whether papillary thyroid cancer (PTC) patients with low-to
intermediate-risk disease should receive radioactive iodine (RAI) after total thyroidectomy …

Objective Identify and appraise clinical practice guidelines (CPGs) for radioactive iodine
(RAI) indications in differentiated thyroid carcinoma (DTC), and the treatment for radioactive …

Bambusurils, BU [4] and BU [6], were used for the first time as multivalent scaffolds to link
glycosidases inhibitors derived from 1-deoxynojirimycin (DNJ). Two linear DNJ ligands …

Thyroid surgery remains an essential treatment of thyroid cancer. The historical one-size-fits-
all approach to differentiated (papillary and follicular) thyroid carcinoma of total …

This study confirmed the effect of sodium/iodine symporter (NIS) expression on existing
drugs by in vitro and in vivo tests using cultured cell lines. The tumor growth inhibitory effect …

This chapter reviews the basics of molecular imaging in thyroid disease and special
considerations in radioiodine therapy of benign diseases such as Graves' disease …